Skip to content
Catalyst

PapersPMID:22166897

Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons.

European journal of clinical nutrition2012The record ↗

findings
5
compound
1
endpoints
5
no difference found
3
PMID:22166897
  1. Finding, limited evidencelowersTotal cholesterol (TC)
  2. Finding, limited evidencelowersLDL cholesterol
  3. Finding, limited evidenceno difference foundBody mass index
  4. Finding, limited evidenceno difference foundBody mass
  5. Finding, limited evidenceno difference foundGlycated haemoglobin (HbA1c)
Study, every finding
crossover · 6 weeks
Dose studied, every finding
5 dl rose hip drink per day for 6 weeks
  • “Intake of the rose hip drink was found to result in a small but significant reduction in plasma levels of total cholesterol (−4.9% P=0.0018), as well as LDL cholesterol (−6.0% P=0.012), compared the intake of the control drink.”
    • Population
      Obese adults (BMI > 30) without diabetes, some with impaired glucose tolerance, on an energy-restricted diet in both periods; eight on statins
    • Population
      Obese adults (BMI > 30) without diabetes, some with impaired glucose tolerance, on an energy-restricted diet in both periods; eight on statins

What did not

  • “Daily intake of the rose hip drink was found to have no effect on body weight and body mass index (Table 3).”
  • “Furthermore, no effects were observed on HbA1c or fasting levels of plasma glucose and insulin (Table 3), indicating that rose hip intake had no effects on glucose tolerance or insulin sensitivity.”
    Population
    Obese adults (BMI > 30) without diabetes, some with impaired glucose tolerance, on an energy-restricted diet in both periods

Study record

Design
crossover trial
Species
human
Population
Obese individuals (body mass index>30) with normal or impaired glucose tolerance, Lund University Hospital
Participants
31
Comparator
placebo
Duration
42 days
Endpoints measured
24